Ev0-Tech Founder Dan Vega Responds to CDM May 2026 SMB Report Highlighting Small Businesses as Fastest-Growing Attack Surface
Evolution Technologies (Ev0-Tech) is featured in Cyber Defense Magazine's May 2026 SMB report, which identifies small businesses as the fastest-growing attack surface, validating the firm's Security F...
Search Atlas Launches Atlas Agent With Domain Power and LLM Visibility Metrics
Search Atlas unveiled Atlas Agent, an autonomous AI system that executes full-stack digital marketing, alongside proprietary Domain Power and LLM Visibility metrics that measure brand presence in gene...
Keona Health Releases ROI Guidance Highlighting Hidden Costs of Manual Nursing Triage
Keona Health's new ROI guidance and calculator quantify the operational and financial impact of manual triage versus AI-assisted workflows, showing potential savings and improved accuracy for healthca...
New Survey Reveals 42% of Standing Workers Experience Foot Pain Before Shift Ends, Yet Only 22% Use Orthotic Insoles
A Footminders survey finds that over half of workers who stand or walk for long hours suffer frequent foot pain, with many not using orthotic support despite dissatisfaction with work shoes.
SureNano Science Initiates IND-Enabling Program for Obesity Drug GEP-44, Aiming for Clinical Trials
SureNano Science has started a GLP toxicology and pharmacology program for its lead candidate GEP-44, targeting obesity and type 2 diabetes, positioning for clinical trials in the rapidly expanding GL...
Springs Rejuvenation Expands Regenerative Medicine and Hair Restoration Services to Atlanta
Springs Rejuvenation has opened its fifth U.S. clinic in Atlanta, offering stem cell exosome therapy, advanced FUE hair restoration, and regenerative joint protocols under one roof to meet growing dem...
Wisconsin’s First Dedicated Emergency Mental Health Facility Opens at Emplify Health by Gundersen
Emplify Health by Gundersen has opened the EmPATH unit, Wisconsin's first dedicated emergency mental health facility, designed to provide immediate, specialized care for patients in mental health cris...
Choosing the Right Oral Rinse: Experts Say Personalization Is Key to Oral and Overall Health
Oral care experts emphasize that selecting an oral rinse should be based on individual health needs, as research links oral health to systemic conditions like cardiovascular disease and diabetes.
MindBio Therapeutics Expands AI Voice Diagnostics Platform with Fatigue Detection Technology
MindBio Therapeutics announced the development of AI-powered fatigue recognition technology that analyzes voice patterns, intended for integration into its Edge AI Intoxication Detection Kiosks for hi...
HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients
HeartBeam Inc. has initiated a pilot study evaluating its investigational on-demand 12-lead ECG patch in patients with suspected coronary artery disease, aiming to expand ambulatory cardiac monitoring...
Oncotelic Therapeutics Advances Pipeline Through Partnership Strategy Without Dilution
Oncotelic Therapeutics is leveraging partnerships and a deep IP portfolio to advance its pipeline without shareholder dilution, with a GMP Bio joint venture adding $249 million to its balance sheet.
SPARC AI Targets Defense Autonomy Software Opportunity as AI-Driven Drone Warfare Accelerates
SPARC AI is developing a software-only system for GPS-denied navigation and precision targeting in drones, addressing a critical need as defense agencies shift toward scalable autonomous systems.
SureNano Science Advances Next-Generation GLP-1 Candidate GEP-44 as Obesity Drug Market Surpasses $200 Billion Projection
SureNano Science Ltd., through its subsidiary GlucaPharm Inc., is advancing GEP-44, a patented triple agonist peptide targeting GLP-1 and PYY receptors, aiming to differentiate in the rapidly expandin...
CNS Drug Delivery Breakthroughs Open New Biotech Market Opportunities
Innovative nose-to-brain delivery platforms aim to bypass the blood-brain barrier, unlocking significant market potential for treating CNS diseases like Alzheimer's.
Apple to Pay $250 Million Settlement Over iPhone AI Marketing Claims
Apple has agreed to a $250 million settlement in a U.S. lawsuit alleging it misled customers about the capabilities and availability of its Apple Intelligence AI features for iPhones.
Study Links Earlier Immunotherapy Timing to Improved Survival in Late-Stage Solid Tumors
A systematic review in JAMA Network Open suggests that earlier administration of immune checkpoint inhibitor therapies may improve survival outcomes for patients with late-stage solid tumors, though p...
Geopolitical Risks Drive Copper Market Volatility, ING Analysis Shows
Geopolitical uncertainties are causing high volatility in the copper market, with prices swinging on political news rather than fundamentals, according to ING analysis.
MindBio Therapeutics Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands
MindBio Therapeutics is developing an AI-driven voice analysis platform to detect drug and alcohol intoxication in real time, targeting workplace safety, healthcare, and public safety markets.
Voice Analysis AI Could Revolutionize Intoxication Detection, MindBio Therapeutics Advances Noninvasive Diagnostic Platform
MindBio Therapeutics is leveraging AI and voice analysis to detect drug and alcohol intoxication in real-time from short speech samples, offering a noninvasive alternative to traditional methods with ...
Autonomous Drone Software Emerges as Critical Battlefield Advantage as Electronic Warfare Expands
As cheap drones flood battlefields, the next revolution in military tech shifts from hardware to AI software enabling GPS-denied navigation and autonomous targeting, with companies like SPARC AI devel...
SureNano Science Advances Next-Generation GLP-1 Triple Agonist Amid Obesity Epidemic
SureNano Science Ltd., through its subsidiary GlucaPharm Inc., is developing GEP-44, a novel triple agonist peptide for obesity and type 2 diabetes, aiming to improve efficacy and delivery in a rapidl...
PAT Express Marks 20 Years of Logistics Service Across Two Australian Locations
PAT Express Pty Ltd, an Australian-owned freight and logistics company, celebrates its 20th anniversary, highlighting its steady growth and comprehensive services from its Ingleburn and Darra location...
Oncotelic Therapeutics Targets CNS Drug Delivery with Nose-to-Brain Platform as Brain Therapeutics Innovation Accelerates
Oncotelic Therapeutics is leveraging its proprietary intranasal nose-to-brain delivery platform to address the challenge of crossing the blood-brain barrier, targeting Alzheimer's disease and biodefen...
Planet Ventures Targets Space Energy Bottleneck as Power Constraints Threaten Orbital Growth
Planet Ventures Inc. is positioning itself in the orbital power race, addressing the emerging energy bottleneck that threatens satellite networks, AI workloads, and space-based infrastructure.
NanoViricides Highlights Broad-Spectrum Antiviral Need After Hantavirus Cruise Ship Incident
NanoViricides underscores the potential of its broad-spectrum antiviral candidate NV-387 following an Andes hantavirus outbreak on a cruise ship, emphasizing the need for treatments effective against ...
Safe Pro Group Selected for U.S. Army Force-on-Force Combat Training Exercise
Safe Pro Group Inc. (NASDAQ: SPAI) has been invited to demonstrate its SPOTD Edge AI battlefield threat detection system during a U.S. Army Force-on-Force combat training exercise in Q2 2026, showcasi...
Kairos Pharma Sets Virtual Annual Meeting, Discloses Going Concern in SEC Filing
Kairos Pharma announced a virtual annual meeting for June 2026 and disclosed a going concern notice in its 2025 annual report, highlighting financial risks for the clinical-stage biotech.
Lavish Enterprises Acquires Commercial Rights to AI-Powered Freight Platform FleetPath
Lavish Enterprises, Inc. acquires exclusive commercial rights to FleetPath, an AI-native operating system for freight lifecycle operations, positioning the company in the nearly trillion-dollar freigh...